A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Efficacy and Safety of Empasiprubart IV in Adults With Chronic Inflammatory Demyelinating Polyneuropathy

16689ARGX-117-2402OpenA Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Efficacy and Safety of Empasiprubart IV in Adults With Chronic Inflammatory Demyelinating PolyneuropathyIndustrialAdultTreatmentOtherAl-Khalili, YasirMedStar Health and GUMC; Medstar Washington Hospital CenterMedStar Neuroscience & Rehab Research Network16270Wesley McclureWesley Mcclurewesley.mcclure@medstar.net2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>